Identification of core sequences involved in metabolism-dependent nuclear protein binding to the rat insulin-like growth factor I gene

Endocrinology

Volumn 140, Issue 10, 1999, Pages 4761-4771

  Zhu, J L ^a   Pao, C I ^a   Hunter E , Jr ^a   Lin, K W M ^a   Wu, G J ^a   Phillips, L S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORE PROTEIN; HOMEODOMAIN PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; DIABETES MELLITUS; DNA TEMPLATE; EXON; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOME; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN METABOLISM; RAT; STREPTOZOCIN DIABETES; TRANSCRIPTION INITIATION;

EID: 0033305234     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.10.7098     Document Type: Article

References (52)

1. Tertiary structures, receptor binding, and antigenicity of insulin like growth factors
2. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
3. Mini-review: Structure, evolution, expression and regulation of insulin-like growth factors I and II
4. Regulation of insulin-like growth factor I gene expression
5. Nutrition and somatomedin XXVI. Molecular regulati.on of insulin-like growth factor-1 by insulin in cultured rat hepatocytes
6. Effect of epidermal growth factor on insulin-like growth factor-I (IGF-1) and IGF-binding protein synthesis by adult hepatocytes
7. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer
8. Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat
9. Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene
10. Physiological relevance of IGF-I mRNA heterogeneity
11. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA
12. Expression of hepatic insulin-like growth factor-I and insulin-like growth factor-binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats
13. Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor-I
14. Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting and diabetes
15. Transcripts of the insulin-like growth factors I and II in human hepatoma
16. Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone trader growth hormone control
17. Transcription initiation in the two leader exons of the rat IGF- 1 gene occurs from disperse versus localized sites
18. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter
19. In vitro transcription of the rat insulin-like growth factor-I gene
20. Characterization of a rat insulin-like growth factor I gene promoter
21. The major promoter of the rat insulin-like growth factor-I gene binds a protein complex that is required for basal expression
22. Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBPa and LAP
23. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites
24. Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoters
25. Identification of novel promoter and repressor elements in the 5'-flanking regions of the rat insulin-like growth factor-I gene
26. Transcriptional regulation of the rat insulin-like growth factor-I gene involves metabolism-dependent binding of nuclear proteins to a downstream region
27. The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1
28. Rapid activation of rat insulin-like growth factor-I gene transcription by growth hormone reveals no alterations in deoxyribonucleic acid-protein interactions within the major promoter
29. DNA-protein interactions
30. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
31. A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase
32. 'Megaprimer' tethod of PCR-based mutagenesis: The concentration of megaprimer is a critical factor
33. Primer extension analysis of RNA
34. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells
35. Definition of the minimal requirements within the human b-globin gene and the dominant control region for high level expression
36. Importance of introns for expression of mouse ribosomal protein gene rpL32
37. Analysis of the tissue-specific enhancer at the 3' end of the chicken adult b-globin gene
38. Identification of 5' and 3' sequences involved in the regulation of transcription of the human mdr 1 gene in vivo
39. Characterization of a single strong tissue-specific enhancer downstream from the three human genes encoding placental lactogen
40. Endothelial-cell-specific regulation of von Willebrand factor gene expression
41. Characterization of a silencer element in the first exon of the human osteocalcin gene
42. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E(2) in osteoblasts
43. CCAAT/enhancer-binding protein d activates insulin-like growth factor-I gene transcription in osteoblasts
44. Nuclear receptor/AP-1 interaction
45. Homeodomain proteins
46. Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites
47. Protein-protein interactions in gene regulation: The cAMP-CRP Complex sets the specificity of a second DNA-binding protein, the CytR repressor
48. Transcriptional regulation by extracellular signals: Mechanisms and specificity
49. A different combination of transcription factors modulates the expression of the human transferrin promoter in liver and Sertoli cells
50. Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors
51. Binding sites for hepatocyte nuclear factor 3β or 3γ and pancreas transcription factor 1 are required for efficient expression of the gene encoding pancreatic α-amylase